ARNOLD & PORTER KAYE SCHOLER LLP

Lobbying for GENETIX BIOTHERAPEUTICS, INC. · Biotechnology and pharmaceutical company.

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · Massachusetts · House · Senate · $60,000.00 income · posted Apr 17, 2026

Lobbying activity 3

Medicare/Medicaid

Issues and legislation related to access to gene therapies and treatment of rare diseases.

Health Issues

Issues and legislation related to access to gene therapies and treatment of rare diseases.

Pharmacy

Issues related to regulatory incentives for rare disease therapies.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.